After 17 years at Lilly, the head of R&D at Lilly Research Laboratories Steven Paul is retiring. While speaking with R&D Directions, Paul says his accomplishments during that time include debuting three new drugs while leading the neuroscience division, redesigning the discovery aspect of the organization, and bringing in new people to keep the pipeline moving.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.